Caption Guidance vs Reveal LINQ

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Caption Guidance

by Caption Health

Reveal LINQ

by Medtronic

AI Verdict

Tool A, Caption Guidance, is an AI-guided software designed to assist healthcare providers in acquiring diagnostic-quality cardiac ultrasound images, focusing on real-time guidance during the imaging procedure. In contrast, Tool B, Reveal LINQ, is a tiny implantable cardiac monitor that continuously records ECG for long-term detection and diagnosis of cardiac arrhythmias. While both utilize AI in cardiology, they address different diagnostic needs: one for image acquisition and the other for prolonged rhythm monitoring.

Choose Caption Guidance if…

Choose Caption Guidance if your primary need is to empower healthcare providers, including those with less specialized ultrasound training, to confidently acquire diagnostic-quality cardiac ultrasound images in real-time. This tool is ideal for settings where immediate cardiac imaging is crucial for diagnosis or where expanding access to cardiac diagnostics through standardized, AI-guided image acquisition is a priority.

View Caption Guidance →

Choose Reveal LINQ if…

Choose Reveal LINQ if you require continuous, long-term cardiac rhythm monitoring to detect elusive or intermittent arrhythmias over an extended period, up to three years. This implantable device is best suited for patients experiencing symptoms like unexplained syncope or cryptogenic stroke, where a definitive diagnosis requires prolonged ECG surveillance beyond what short-term monitoring can provide.

View Reveal LINQ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Caption Guidance	Reveal LINQ
Deployment	On-premise (integrated with ultrasound equipment) and cloud-based services.	The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs.
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Caption Guidance

Tool A, Caption Guidance, significantly enhances usability by providing real-time AI guidance for ultrasound probe manipulation and automated quality assessment. This empowers a broader range of healthcare providers to acquire diagnostic-quality cardiac ultrasound images, effectively democratizing a complex skill. Tool B focuses more on the ease of implantation and data management of an already implanted device, which is a different aspect of usability.

Clinical Value

Reveal LINQ

Tool B, Reveal LINQ, offers continuous ECG monitoring for up to three years with AI algorithms (AccuRhythmu2122) to accurately detect and diagnose cardiac arrhythmias, significantly reducing false alerts. This long-term, accurate monitoring is crucial for diagnosing intermittent and often elusive cardiac conditions like atrial fibrillation and cryptogenic stroke. While Tool A improves diagnostic image acquisition, Tool B provides a unique, sustained diagnostic capability for hard-to-catch events.

Pricing & Value

Tie

Both tools have opaque pricing models, requiring direct contact with the vendor, making a direct comparison of value difficult. Tool A mentions a subscription model and an introductory price for a direct-to-patient service, but enterprise pricing remains undisclosed. Tool B's pricing is typically integrated into procedure costs and covered by insurance, which is common for implantable medical devices. Without specific, comparable pricing details for providers, it's impossible to determine a winner.

Enterprise Readiness

Caption Guidance

Tool A, Caption Guidance, is now part of GE HealthCare and is designed as a software accessory integrated into compatible GE HealthCare ultrasound systems. This integration with existing, widely used imaging infrastructure, along with explicit FDA clearance, HIPAA compliance, and a Business Associate Agreement (BAA), suggests a highly streamlined and ready deployment for healthcare enterprises already utilizing GE equipment. While Tool B is from Medtronic, a major player, its deployment involves an implantable device and its associated ecosystem, which presents a different set of integration considerations compared to software-based enhancement of existing hardware.

Innovation

Caption Guidance

Tool A, Caption Guidance, is the first FDA-cleared AI-guided software that enables healthcare providers to acquire diagnostic-quality cardiac ultrasound images with real-time guidance. This represents a significant innovation in making a highly skilled diagnostic procedure accessible to a broader range of clinicians, potentially transforming access to critical cardiac diagnostics. While Tool B offers innovative miniaturization and AI-powered accuracy for long-term monitoring, Tool A's approach to democratizing a complex procedural skill through AI guidance is a more foundational innovation in diagnostic workflow.

Support & Docs

Tie

Both Caption Guidance (now part of GE HealthCare) and Reveal LINQ (from Medtronic) are products of large, established medical technology companies. Both GE HealthCare and Medtronic have extensive global support networks and provide comprehensive documentation for their products. Without specific metrics or comparative details on the quality, responsiveness, or breadth of their support and documentation, it is not possible to definitively pick a winner between the two.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Caption Guidance	Reveal LINQ
Product Name	Caption Guidance	Reveal LINQ
Company	Caption Health (now part of GE HealthCare)	Medtronic
Primary Function	AI-guided software for acquiring diagnostic-quality cardiac ultrasound images with real-time guidance and automated quality assessment.	Tiny, implantable cardiac monitor that continuously records ECG for up to three years, utilizing AI algorithms to detect and diagnose cardiac arrhythmias.
Key AI Functionality	Real-time AI guidance for ultrasound probe manipulation, automated quality assessment with a 'Quality Meter', auto-capture of diagnostic-quality ultrasound clips, automated ejection fraction calculation.	AccuRhythmu2122 AI algorithms for reduced false alerts (AF and pause), automatic and patient-activated event recording.
Target Specialties	Cardiology, Critical Care, Radiology	Cardiology, Neurology

Videos

Demos, reviews, and walkthroughs featuring Caption Guidance and Reveal LINQ.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does each tool integrate into existing clinical workflows for cardiac assessment?

Caption Guidance is a software accessory that integrates with compatible ultrasound systems, providing real-time AI guidance during image acquisition to streamline the process for various healthcare providers. Reveal LINQ is an implantable cardiac monitor that continuously records ECG data, which is then transmitted wirelessly to the CareLinku2122 network and managed via a mobile app for clinician review, fitting into a long-term monitoring workflow.

What are the key differences in how each tool leverages AI for diagnostic accuracy and sensitivity?

Caption Guidance uses AI to provide real-time guidance for ultrasound probe manipulation and automated quality assessment, ensuring the acquisition of diagnostic-quality cardiac ultrasound images and automated ejection fraction calculation. Reveal LINQ utilizes AccuRhythmu2122 AI algorithms to analyze continuous ECG data, accurately detecting and diagnosing cardiac arrhythmias while significantly reducing false alerts for atrial fibrillation and pause.

For which specific clinical scenarios or patient populations is each tool best suited?

Caption Guidance is ideal for improving access to and quality of cardiac ultrasound imaging, particularly in point-of-care settings like emergency departments or critical care, empowering a broader range of healthcare professionals to perform scans. Reveal LINQ is best suited for patients requiring long-term, continuous monitoring for suspected or elusive cardiac arrhythmias, cryptogenic stroke, or unexplained syncope, providing data for up to three years.

What is the expected learning curve for clinicians and how quickly can a practice realize value from each tool?

Caption Guidance is designed to significantly reduce the learning curve for acquiring quality cardiac ultrasounds, with studies showing nurses with minimal training can achieve diagnostic-quality images, enabling rapid adoption and immediate value in expanding imaging access. The Reveal LINQ insertion procedure is minimally invasive and simplified, and clinicians manage data via an app, with value realized over the device's continuous, long-term monitoring period for arrhythmia detection.

What kind of audit trail or data logging capabilities does each tool offer for clinical review and accountability?

Caption Guidance provides automated quality assessment and auto-capture of diagnostic-quality ultrasound clips, inherently logging the quality and acquisition of cardiac ultrasound images. Reveal LINQ offers continuous ECG recording, automatic and patient-activated event logging, and wireless data transmission to the CareLinku2122 network, providing a comprehensive and detailed audit trail of cardiac events over an extended period.

How does each tool facilitate the integration of its generated data into a physician's existing Electronic Health Record (EHR) system?

As a software accessory for ultrasound systems, Caption Guidance's generated images and measurements would typically flow through existing imaging PACS and EMR integrations. Reveal LINQ data is transmitted to the cloud-based CareLinku2122 network, and reports are automatically populated there, from which integration with EHRs would typically occur for long-term ECG data and event reporting.

What are the primary considerations for deploying and managing each tool across multiple clinical sites or hospital systems?

For Caption Guidance, multi-site rollout involves integrating the software with compatible ultrasound systems at each location and training staff on the AI-guided acquisition protocols. For Reveal LINQ, deployment across multiple sites requires standardized minimally invasive insertion procedures, patient education for remote monitoring via the MyCareLinku2122 Patient Monitor, and centralized management of data through the CareLinku2122 network.